Healthcare Services APAC

APAC Metabolic Surgery Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC Metabolic Surgery Market Industry Trends and Forecast to 2034: Segmented by (Procedure, Approach, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.00 Bn Placeholder estimate
Estimate 2025 $2.16 Bn 21.2% of the global market
Projected 2034 $4.28 Bn 98.2% Adds $2.12 Bn over 9 forecast years
CAGR 2025–2034 7.9% Faster than 18% of 107 Healthcare Services markets here
Key players 5
  • APAC is 21.15% of the global market.
  • Among regions, the largest is North America at $5.27 Bn.
  • Fastest growing: Africa at 8% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.12 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Metabolic Surgery Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.00 Bn — —
2025 (base) $2.16 Bn +$158.1 Mn —
2026 (forecast) $2.33 Bn +$170.6 Mn +7.9%
2027 (forecast) $2.51 Bn +$184.1 Mn +16.4%
2028 (forecast) $2.71 Bn +$198.6 Mn +25.6%
2029 (forecast) $2.93 Bn +$214.3 Mn +35.5%
2030 (forecast) $3.16 Bn +$231.2 Mn +46.3%
2031 (forecast) $3.41 Bn +$249.5 Mn +57.8%
2032 (forecast) $3.68 Bn +$269.2 Mn +70.3%
2033 (forecast) $3.97 Bn +$290.5 Mn +83.7%
2034 (forecast) $4.28 Bn +$313.4 Mn +98.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Metabolic Surgery Market Analysis at a glance
Market size, 2025$2.16 Bn placeholder estimate
Forecast, 2034$4.28 Bn placeholder estimate
Growth (CAGR), 2025–20347.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProcedure, approach and end user (see all)
Key playersMedtronic, Johnson & Johnson, Intuitive Surgical, Olympus Corporation, Teleflex Inc (see all)
Active clinical trials61 in Asia PacificSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Asia Pacific. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Metabolic Surgery Market Analysis Executive Summary

Metabolic surgery uses weight-loss operations to treat type 2 diabetes and other metabolic diseases, not only to reduce weight.

Key segments of the metabolic Surgery market include procedure (Sleeve Gastrectomy, Roux-en-Y Gastric Bypass and Duodenal Switch) and approach (Laparoscopic, Robotic-Assisted and Endoscopic).

Bar chart: Asia Pacific Metabolic Surgery market size, 2024–2034, placeholder estimates. $2.00 Bn in 2024, $2.16 Bn in 2025 and $4.28 Bn in 2034, 7.9% CAGR.
Asia Pacific Metabolic Surgery market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Metabolic Surgery Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the metabolic Surgery market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the metabolic Surgery market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the metabolic Surgery market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Metabolic Surgery Market in APAC

The metabolic Surgery market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Metabolic Surgery Market in APAC

Metabolic Surgery in APAC: payment and research

How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[1], basic medical insurance (China)⁠[2], the Hospital Authority (Hong Kong)⁠[3], Ayushman Bharat PM-JAY (India)⁠[4], public health insurance (Japan)⁠[5], subsidised public care (Malaysia)⁠[6], Pharmac (New Zealand)⁠[7], PhilHealth (Philippines)⁠[8], MediShield Life (Singapore)⁠[9] and the Universal Coverage Scheme (Thailand)⁠[10]. ClinicalTrials.gov lists 61 studies on Metabolic Surgery that are recruiting, active or about to start in APAC.⁠[11]

[1] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[2] National Healthcare Security Administration. Checked 14 Nov 2026.

[3] Hospital Authority. Checked 14 Nov 2026.

[4] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[5] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[6] Ministry of Health Malaysia. Checked 14 Nov 2026.

[7] Pharmac. Checked 14 Nov 2026.

[8] PhilHealth. Checked 14 Nov 2026.

[9] CPF Board, MediShield Life. Checked 14 Nov 2026.

[10] National Health Security Office. Checked 14 Nov 2026.

[11] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in APAC. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how metabolic Surgery services are delivered and paid for in APAC. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Metabolic Surgery right now, from free public sources.

Clinical trials

61 active trials in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand, Bangladesh, Afghanistan, Indonesia, Myanmar, Nepal and Pakistan

Recruiting, about to start, or running now. Counted across the 16 countries we report on in APAC.

Top trial sponsors (worldwide)

  1. Eli Lilly and Company 9 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Novo Nordisk A/S 8 active trials on ClinicalTrials.gov (opens in a new tab)
  3. GT Metabolic Solutions, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Roche 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Duomed 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Patients

Obesity (adults), % of adults (WHO)
CountryValueYear
Afghanistan20.62024
Australia30.62024
Bangladesh5.82024
China9.32024
India8.02024
Indonesia11.82024
Japan5.92024
Malaysia23.32024
Myanmar8.12024
Nepal8.02024
New Zealand34.02024
Pakistan24.52024
Philippines9.62024
Singapore17.02024
Thailand16.42024
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Metabolic Surgery in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Metabolic Surgery market in Asia Pacific?
Placeholder estimate: about $2.16 Bn in 2025, rising to about $4.28 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Metabolic Surgery market in Asia Pacific growing?
Placeholder estimate: about 7.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Metabolic Surgery market report cover?
The report splits the market by procedure (Sleeve Gastrectomy, Roux-en-Y Gastric Bypass, Duodenal Switch, Revisional Surgery), approach (Laparoscopic, Robotic-Assisted, Endoscopic) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Metabolic Surgery market?
Key players include Medtronic, Johnson & Johnson, Intuitive Surgical, Olympus Corporation and Teleflex Inc.
What is driving the Metabolic Surgery market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the metabolic Surgery market.
How many clinical trials on Metabolic Surgery are running in Asia Pacific?
61 studies are recruiting, active or about to start in Asia Pacific, counted across the 16 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Asia Pacific. Retrieved 12 Nov 2026.
How much research is published on Metabolic Surgery?
PubMed lists 1,452 papers on Metabolic Surgery added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in APAC

See all

Related on obesity and diabetes

See the topic